heroin and Obesity

heroin has been researched along with Obesity* in 5 studies

Other Studies

5 other study(ies) available for heroin and Obesity

ArticleYear
Comprehensive assessment of neurocognitive function, inflammation markers, and adiposity in treated HIV and control.
    Medicine, 2022, Oct-21, Volume: 101, Issue:42

    To compare the neurocognitive scores between persons living with human immunodeficiency virus (PLWH) and persons without human immunodeficiency virus (HIV) and assess the relationship between neurocognition, HIV status and variables, inflammation, and body composition measures. Cross-sectional study involving 225 participants (126 PLWH on antiretroviral therapy [ART] and 99 persons without HIV). For the first time in HIV, we used Cognivue®, an food and drug administration (FDA)-approved computer-based test to assess cognitive function. The test was calibrated to individuals' unique cognitive ability and measured 6 cognitive domains and 2 performance parameters. Markers of inflammation, immune activation, insulin resistance, and body fat composition (using dual-energy X-ray absorptiometry scan) were collected. Classical t tests, chi-square tests, and spearman correlations were used to compare and explore relationships between variables. Inverse probability weighting adjusted average treatment effect models were performed to evaluate the differences between PLWH and persons without HIV, adjusting for age, race, sex, and heroin use. Overall, 64% were male, 46% were Black, with a mean age of 43 years. Among PLWH, 83% had an undetectable HIV-1 RNA level (≤20 copies/mL). Compared persons without HIV, PLWH performed poorer across 4 domains: visuospatial (P = .035), executive function (P = .029), naming/language (P = .027), and abstraction (P = .018). In addition, PLWH had a significantly longer processing speed time compared to controls (1686.0 ms vs 1606.0 ms [P = .007]). In PLWH, lower cognitive testing domain scores were associated with higher inflammatory markers (high sensitivity C-reactive protein [hsCRP]) and with higher total fat and visceral adipose tissue (P < .05). Neurocognitive impairment (NCI) in HIV is associated with inflammation and total and central adiposity.

    Topics: Adiposity; Adult; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Female; Heroin; HIV Infections; Humans; Inflammation; Male; Obesity; RNA

2022
Is low BMI associated with specific drug use among injecting drug users?
    Substance use & misuse, 2014, Volume: 49, Issue:4

    Body mass index (BMI) of a sample of people who regularly inject drugs (N = 781) was examined to gauge the impact of specific types of drug use. Cross-sectional interviews were undertaken in 2010 as part of a national monitoring program funded by the Australian Government. Latent class analysis identified three groups of drug users, with heroin users at 3.4 times the risk of being underweight compared with amphetamine users, and amphetamine users were at almost twice the odds of being obese compared with lower level morphine users. Nutrition should play a part in harm minimization.

    Topics: Adolescent; Adult; Amphetamine; Australia; Body Mass Index; Cross-Sectional Studies; Female; Heroin; Humans; Male; Middle Aged; Morphine; Obesity; Overweight; Qualitative Research; Substance Abuse, Intravenous; Thinness; Young Adult

2014
Nutritional status of deceased illicit drug addicts in Stockholm, Sweden--a longitudinal medicolegal study.
    Journal of forensic sciences, 2004, Volume: 49, Issue:2

    Autopsy investigations, toxicological analyses, and calculation of body mass index were performed in 1180 deceased illicit drug addicts (IDAs) in Stockholm. Sweden during 1988-2000, i.e., during a period of time when the general population in numerous countries showed a dramatic increase in the prevalence of overweight. Nutritional deficit in IDAs has been pointed out as a threat to their health as well as to their quality of life. The prevalence of overweight in deceased IDAs increased from 27.4% in 1988 to 45.5% in 2000. The prevalence of overweight among all heroin users, heroin injectors, methadone, cocaine, and amphetamine users was 36.0, 38.4, 43.1, 45.0 and 50.9%, respectively, the lowest prevalence being among users of cannabis alone and HIV-positive IDAs (22.0 and 16.1%, respectively). In conclusion, Stockholm's IDAs are affected by the past decade's dramatically increased prevalence of overweight, at least to the same degree as the general population. The increased body weight seems not to influence the danger of dying upon heroin administration.

    Topics: Adolescent; Adult; Age Distribution; Amphetamine; Body Mass Index; Cannabis; Cocaine; Dopamine Uptake Inhibitors; Female; Heroin; HIV Infections; Humans; Longitudinal Studies; Male; Methadone; Narcotics; Nutritional Status; Obesity; Prevalence; Sex Distribution; Substance-Related Disorders; Sweden

2004
Therapeutic uses of the drugs of abuse.
    Annals of the New York Academy of Sciences, 1981, Volume: 362

    Topics: Amphetamines; Behavior; Cannabis; Drug Therapy; Epilepsy; Heroin; Humans; Illicit Drugs; Lysergic Acid Diethylamide; Mental Disorders; Nausea; Obesity; Pain; Vomiting

1981
A study of phenmetrazine (Preludin) abuse.
    Chemical dependencies, 1980, Volume: 4, Issue:1-2

    Topics: Adolescent; Adult; Age Factors; Appetite Depressants; Black or African American; Body Weight; Data Collection; Drug and Narcotic Control; Female; Heroin; Heroin Dependence; Humans; Injections, Intravenous; Male; Obesity; Phenmetrazine; Random Allocation; Sex Factors; Substance-Related Disorders; United States; White People

1980